<!doctype html><html class=no-js lang=en><head><meta charset=UTF-8><meta name=viewport content="width=device-width,initial-scale=1"><title>ç§‘ç ”æ—¥æŠ¥ 2026-02-15 - ç”Ÿä¿¡æ™®æ‹‰æ–¯</title>
<script>(function(e,t){e[t]=e[t].replace("no-js","js")})(document.documentElement,"className")</script><meta name=description content><meta property="og:url" content="https://ixxmu.github.io/posts/dailyreports/2026-02-15/"><meta property="og:site_name" content="ç”Ÿä¿¡æ™®æ‹‰æ–¯"><meta property="og:title" content="ç§‘ç ”æ—¥æŠ¥ 2026-02-15"><meta property="og:description" content="ğŸ“… Daily Report - 2026-02-15 ä»Šæ—¥ç­›é€‰å‡º 43 æ¡å†…å®¹ï¼Œæ¥è‡ª 2 ä¸ªæ¥æº"><meta property="og:locale" content="zh_cn"><meta property="og:type" content="article"><meta property="article:section" content="posts"><meta property="article:published_time" content="2026-02-15T00:00:00+00:00"><meta property="article:modified_time" content="2026-02-15T00:00:00+00:00"><meta property="article:tag" content="Research"><meta property="article:tag" content="Daily"><meta property="article:tag" content="Week072026"><meta itemprop=name content="ç§‘ç ”æ—¥æŠ¥ 2026-02-15"><meta itemprop=description content="ğŸ“… Daily Report - 2026-02-15 ä»Šæ—¥ç­›é€‰å‡º 43 æ¡å†…å®¹ï¼Œæ¥è‡ª 2 ä¸ªæ¥æº"><meta itemprop=datePublished content="2026-02-15T00:00:00+00:00"><meta itemprop=dateModified content="2026-02-15T00:00:00+00:00"><meta itemprop=wordCount content="2501"><meta itemprop=keywords content="Research,Daily,Week072026"><meta name=twitter:card content="summary"><meta name=twitter:title content="ç§‘ç ”æ—¥æŠ¥ 2026-02-15"><meta name=twitter:description content="ğŸ“… Daily Report - 2026-02-15 ä»Šæ—¥ç­›é€‰å‡º 43 æ¡å†…å®¹ï¼Œæ¥è‡ª 2 ä¸ªæ¥æº"><link rel=preconnect href=https://fonts.gstatic.com crossorigin><link rel=dns-prefetch href=//fonts.googleapis.com><link rel=dns-prefetch href=//fonts.gstatic.com><link rel=stylesheet href="https://fonts.googleapis.com/css?family=Open+Sans:400,400i,700"><link rel=stylesheet href=../../../css/style.css><link rel=stylesheet href=../../../css/custom.css><link rel="shortcut icon" href=../../../favicon.ico></head><body class=body><div class="container container--outer"><header class=header><div class="container header__container"><div class=logo><a class=logo__link href=../../../ title=ç”Ÿä¿¡æ™®æ‹‰æ–¯ rel=home><div class="logo__item logo__text"><div class=logo__title>ç”Ÿä¿¡æ™®æ‹‰æ–¯</div><div class=logo__tagline>è¿‘åå¹´æœ€å€¼å¾—ä¸Šæ‰‹çš„ç”Ÿç‰©åŒ»å­¦ç”Ÿä¿¡ä»£ç </div></div></a></div><nav class=menu><button class=menu__btn aria-haspopup=true aria-expanded=false tabindex=0>
<span class=menu__btn-title tabindex=-1>Menu</span></button><ul class=menu__list><li class=menu__item><a class=menu__link href=../../../posts/><span class=menu__text>æ–‡ç« </span></a></li><li class=menu__item><a class=menu__link href=../../../tags/><span class=menu__text>æ ‡ç­¾</span></a></li><li class=menu__item><a class=menu__link href=../../../about/><span class=menu__text>å…³äº</span></a></li></ul></nav></div></header><div class="wrapper flex"><div class=primary><main class=main role=main><article class=post><header class=post__header><meta name=referrer content="never"><h1 class=post__title>ç§‘ç ”æ—¥æŠ¥ 2026-02-15</h1><div class="post__meta meta"><div class="meta__item-datetime meta__item"><svg class="meta__icon icon icon-time" width="16" height="14" viewBox="0 0 30 28"><path d="M15 0a14 14 0 110 28 1 1 0 010-28m0 3a3 3 0 100 22 3 3 0 000-22m1 4h-2v8.4l6.8 4.4L22 18l-6-3.8z"/></svg><time class=meta__text datetime=2026-02-15T00:00:00Z>2026-02-15</time></div><div class="meta__item-categories meta__item"><svg class="meta__icon icon icon-category" width="16" height="16" viewBox="0 0 16 16"><path d="m7 2 1 2h8v11H0V2z"/></svg><span class=meta__text><a class=meta__link href=../../../categories/dailyreport/ rel=category>DailyReport</a></span></div><div class="meta__item-author meta__item"><svg class="meta__icon icon icon-author" width="16" height="16" viewBox="0 0 16 16"><path d="M8 1c2 0 3.5 2 3.5 4.5S10 9 10 9c3 1 4 2 4 6H2c0-4 1-5 4-6 0 0-1.5-1-1.5-3.5S6 1 8 1"/></svg><span class=meta__text>Bloger</span></div></div></header><div class="post__toc toc"><div class=toc__title>Page content</div><div class=toc__menu><nav id=TableOfContents><ul><li><a href=#-ä»Šæ—¥aiæ™ºèƒ½æ€»ç»“>ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“</a><ul><li><a href=#-æ•°æ®å‰æ²¿>ğŸ§¬ æ•°æ®å‰æ²¿</a></li><li><a href=#-åšå®¢æ›´æ–°>ğŸ§ª åšå®¢æ›´æ–°</a></li></ul></li><li><a href=#-åˆ†ç±»æµè§ˆ>ğŸ“š åˆ†ç±»æµè§ˆ</a><ul><li></li></ul></li><li><a href=#-å…³é”®è¯ç»Ÿè®¡>ğŸ“Š å…³é”®è¯ç»Ÿè®¡</a></li><li><a href=#-æ›´å¤šå†…å®¹>ğŸ“ æ›´å¤šå†…å®¹</a></li></ul></nav></div></div><div class="content post__content clearfix"><h1 id=-daily-report---2026-02-15>ğŸ“… Daily Report - 2026-02-15</h1><blockquote><p>ä»Šæ—¥ç­›é€‰å‡º <strong>43</strong> æ¡å†…å®¹ï¼Œæ¥è‡ª <strong>2</strong> ä¸ªæ¥æº</p></blockquote><div class=powered-by-top>Powered by <a href=https://kyplus.de>ç§‘ç ”æ™®æ‹‰æ–¯</a> & <a href=https://claude.ai>Claude</a></div><hr><h2 id=-ä»Šæ—¥aiæ™ºèƒ½æ€»ç»“>ğŸ¤– ä»Šæ—¥AIæ™ºèƒ½æ€»ç»“</h2><h3 id=-æ•°æ®å‰æ²¿>ğŸ§¬ æ•°æ®å‰æ²¿</h3><blockquote><p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š
PKM2ä¹³é…¸åŒ–åœ¨ç»“ç›´è‚ ç™Œè¡€ç®¡ç”Ÿæˆæ¨¡æ‹Ÿå’Œè€è¯æœºåˆ¶ä¸­èµ·å…³é”®ä½œç”¨ï¼Œé€šè¿‡è°ƒæ§FOSL1è¶…çº§å¢å¼ºå­å½¢æˆã€‚</p></blockquote><p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š</p><ul><li>è‚¿ç˜¤å…ç–«å¾®ç¯å¢ƒè°ƒæ§ï¼šé€šè¿‡è¡¨è§‚é—ä¼ å­¦å¼€å…³è°ƒèŠ‚è¡€ç®¡è¡¨å‹ï¼Œå¢å¼ºæŠ—è‚¿ç˜¤å…ç–«ï¼›Tç»†èƒè€—ç«­è¿›åŒ–ä¸æ·‹å·´ç»“å¾®ç¯å¢ƒã€‚</li><li>ç™Œç—‡è€è¯æœºåˆ¶ï¼šPKM2ä¹³é…¸åŒ–ä»‹å¯¼çš„è¡€ç®¡ç”Ÿæˆæ¨¡æ‹Ÿï¼›SMARCA4è°ƒæ§PROX1å’ŒH3K27ä¹™é…°åŒ–æŠµæŠ—å‰åˆ—è…ºç™Œæ©æ‰å¢èƒºã€‚</li><li>è‚ é“å…ç–«ç¨³æ€ï¼šæ ‘çªçŠ¶ç»†èƒäº§ç”ŸIFN-Î»ï¼›Caspases 3/7è°ƒæ§è‚ é“ç‚ç—‡å’Œç»†èƒç„¦äº¡ã€‚</li></ul><p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š</p><ul><li>ç»“åˆå•ç»†èƒRNA-seqï¼ˆscRNA-seqï¼‰ã€å…¨åŸºå› ç»„ç»“åˆ/å æœ‰ç‡æµ‹åºï¼ˆATAC-seq, ChIP-seq, CUT&amp;Tagï¼‰ç­‰å¤šç»„å­¦æŠ€æœ¯ï¼Œæ·±å…¥è§£æç»†èƒå¼‚è´¨æ€§å’Œè°ƒæ§æœºåˆ¶ã€‚</li><li>å»ºç«‹ä½“å¤–3Dç»†èƒåŸ¹å…»æ¨¡å‹ï¼Œæ¨¡æ‹Ÿä¹³è…ºç™Œç»†èƒæ°§åŒ–ä»£è°¢ï¼Œä¸ºç ”ç©¶æä¾›æ–°å¹³å°ã€‚</li></ul><h3 id=-åšå®¢æ›´æ–°>ğŸ§ª åšå®¢æ›´æ–°</h3><blockquote><p><strong>ä»Šæ—¥ç„¦ç‚¹</strong>ï¼š
é¦–æ¬¡åˆ©ç”¨Nanoporeæµ‹åºæŠ€æœ¯ï¼Œå®ç°å¯¹å®Œæ•´æ°¨é…°åŒ–tRNAï¼ˆaa tRNAï¼‰çš„ç›´æ¥æµ‹åºï¼Œä»è€Œé‰´å®šä¸ªä½“tRNAä¸Šçš„æ°¨åŸºé…¸é™„ç€æƒ…å†µã€‚</p></blockquote><p><strong>ä¸»è¦æ–¹å‘</strong>ï¼š</p><ul><li>æ­ç¤ºtRNAä¿®é¥°å¦‚ä½•å½±å“å…¶ç¨³å®šæ€§å’Œæ°¨é…°åŒ–æ•ˆç‡ã€‚</li><li>æ¢ç´¢ä¸åŒæ°¨åŸºé…¸åœ¨tRNAä¸Šçš„åˆ†å¸ƒåŠä¸ç¿»è¯‘è¿‡ç¨‹çš„å…³è”ã€‚</li></ul><p><strong>æŠ€æœ¯äº®ç‚¹</strong>ï¼š</p><ul><li>å¼€å‘äº†æ–°å‹çš„aa tRNAæµ‹åºï¼ˆaa tRNA seqï¼‰æ–¹æ³•ï¼Œç»“åˆNanoporeé•¿è¯»é•¿å’Œç›´æ¥æ£€æµ‹èƒ½åŠ›ã€‚</li></ul><hr><h2 id=-åˆ†ç±»æµè§ˆ>ğŸ“š åˆ†ç±»æµè§ˆ</h2><details><summary style="text-align:right;direction:rtl;padding:10px 15px;background:linear-gradient(135deg,#f8f9fa 0%,#e9ecef 100%);border-right:4px solid #667eea;font-weight:600;cursor:pointer;margin:15px 0;border-radius:6px">ğŸ§¬ æ•°æ®å‰æ²¿ (42æ¡)</summary><div class=details-content markdown=1><h4 id=è¯¦ç»†å†…å®¹å‰10æ¡>è¯¦ç»†å†…å®¹ï¼ˆå‰10æ¡ï¼‰</h4><p><strong>1.</strong> â­ <strong>GSE319479 è¡€ç®¡è¡¨å‹ä¸­çš„è¡¨è§‚é—ä¼ è½¬æ¢å¢å¼ºæŠ—è‚¿ç˜¤å…ç–«åŠ› [scRNA-seq]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€immunityã€scRNAã€epigenetic</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Dae Joong Kim ; Mitchell McGinty ; Swetha Anandh ; Caroline Riedstra ; Yuvraj Sethi ; Melanie Rutkowski ; Andrew DudleySeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusThe abnormal tumor vasculature can present a barrier to the infiltration of anti-tumor immune cells, which impairs immune surveillance and response to immunotherapy. Here, we show that targeting the epigenetic factor DNA methyltransferase 1 in endothelial cells (ECs) results in reduced angiogenesis while imparting profound changes to the tumor immune microenvironment (TIME), including increased proportions of CD4+ memory T-cells and NK cells. Depleting CD4+ T-cells, or blocking lymphocyte egress from the lymph nodes with FTY720, rescues tumor growth in mice with conditional deletion of Dnmt1 in ECs (Dnmt1iECKO) and dramatically shortens overall survival, whereas NK cells are dispensable. Tumors implanted in Dnmt1iECKO mice show reduced vascular branching, elevated expression of Vcam1, increased vessel-associated T-cells, and a shift in vascular specification including increased proportions of immune-permissive post-capillary venules (PCVs) and interferon-stimulated ECs (IFN_x0002_ECs). Deleting Dnmt1 in EC cultures strikingly potentiates responses to combinations of IFNg and TNFa and, notably, up-regulates important T-cell co-stimulatory molecules for memory CD4+ T-cells, including Icosl, Cd40, and Tnfsf4. Finally, immune checkpoint blockade (ICB) administered to Dnmt1iECKO mice with experimental melanoma lung metastasis reduces tumor burden, with some mice showing tumor eradication. Our findings identify endothelial Dnmt1 as a key regulator of vascular-mediated anti-tumor immunity, providing a rationale for integrating epigenetic modulation of the vasculature with cancer immunotherapy regimens.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE319479">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>2.</strong> â­ <strong>GSE318850 æ·‹å·´ç»“-è‚¿ç˜¤è€—ç«­Tç»†èƒå…‹éš†æ¼”åŒ–çš„æ—¶ç©ºå›¾è°±</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€lymphã€T cellã€regex:lymph(o|atic)?</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Yang Zhang ; Haiquan ChenSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensCurrent surgical guidelines overlook preserving uninvolved lymph nodes (uiLNs) in non-small cell lung cancer, principally stemming from an underappreciation of their critical role in anti-tumor immunity. Here, we discovered a significant immunosuppressive microenvironment in metastatic lymph nodes. In contrast, CD200+ progenitor exhausted T cells (Tpex) markedly expanded within uiLNs following immunotherapy. Effective clonal sharing of exhausted T cells between uiLNs and tumors correlated strongly with complete pathological response. Previously unrecognized tumor-resident C1QA+ dendritic cells secreted CXCL9, facilitating T cell recruitment, whereas fibroblast-enriched neighborhoods in non-responders created immunosuppressive barriers hindering CXCL9 diffusion and CD200+ Tpex migration. Finally, we confirmed that tumor-reactive Tex clones from uiLNs could persist systemically and identified two neoantigen peptides as direct targets of these tumor-reactive Tex cells. Our study unprecedentedly elucidates the spatiotemporal dynamics of immunotherapy-responsive T cell subsets in LN-tumor axis and provides compelling evidence to support selective LN dissection strategies to preserve uiLNs.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE318850">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>3.</strong> â­ <strong>GSE319480 è¡€ç®¡è¡¨å‹ä¸­çš„è¡¨è§‚é—ä¼ è½¬æ¢å¢å¼ºæŠ—è‚¿ç˜¤å…ç–«åŠ› [bulkRNA-seq]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼štumorã€immunityã€epigenetic</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Dae Joong Kim ; Mitchell McGinty ; Swetha Anandh ; Caroline Riedstra ; Yuvraj Sethi ; Melanie Rutkowski ; Andrew DudleySeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusThe abnormal tumor vasculature can present a barrier to the infiltration of anti-tumor immune cells, which impairs immune surveillance and response to immunotherapy. Here, we show that targeting the epigenetic factor DNA methyltransferase 1 in endothelial cells (ECs) results in reduced angiogenesis while imparting profound changes to the tumor immune microenvironment (TIME), including increased proportions of CD4+ memory T-cells and NK cells. Depleting CD4+ T-cells, or blocking lymphocyte egress from the lymph nodes with FTY720, rescues tumor growth in mice with conditional deletion of Dnmt1 in ECs (Dnmt1iECKO) and dramatically shortens overall survival, whereas NK cells are dispensable. Tumors implanted in Dnmt1iECKO mice show reduced vascular branching, elevated expression of Vcam1, increased vessel-associated T-cells, and a shift in vascular specification including increased proportions of immune-permissive post-capillary venules (PCVs) and interferon-stimulated ECs (IFN_x0002_ECs). Deleting Dnmt1 in EC cultures strikingly potentiates responses to combinations of IFNg and TNFa and, notably, up-regulates important T-cell co-stimulatory molecules for memory CD4+ T-cells, including Icosl, Cd40, and Tnfsf4. Finally, immune checkpoint blockade (ICB) administered to Dnmt1iECKO mice with experimental melanoma lung metastasis reduces tumor burden, with some mice showing tumor eradication. Our findings identify endothelial Dnmt1 as a key regulator of vascular-mediated anti-tumor immunity, providing a rationale for integrating epigenetic modulation of the vasculature with cancer immunotherapy regimens.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE319480">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>4.</strong> â­ <strong>GSE307937 PKM2 ä¹³é…¸åŒ–ä¿ƒè¿›ç»“ç›´è‚ ç™Œè¡€ç®¡ç”Ÿæˆæ‹Ÿæ€å’Œå¯¹è´ä¼å•æŠ—æ²»ç–—çš„è€è¯æ€§ï¼Œé€šè¿‡ä¿ƒè¿› FOSL1 è¶…çº§å¢å¼ºå­å½¢æˆ [RNA-Seq]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€resistanceã€RNA-seq</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Weihao Li ; Jianhong Peng ; Jiahua He ; Zhizhong Pan ; Chi Zhou ; Junzhong LinSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensDespite the clinical utility of bevacizumab in advanced colorectal cancer (CRC), resistance remains a major challenge. Here, we unveiled a lactate-mediated mechanism driving vasculogenic mimicry (VM) and bevacizumab resistance through PKM2 lactylation. PKM2 lactylation at K206 by AARS1 promoted PKM2 nuclear translocation and interaction with FOSL1. PKM2 binding facilitated FOSL1-dependent super-enhancer formation and target gene transcription, which contributed to CRC cell VM. Genetic or pharmacological inhibition of PKM2 lactylation disrupted VM and synergized with bevacizumab in patient-derived pre-clinical models, significantly improving therapeutic efficacy. Together, this study reveals lactylation as a metabolic switch linking cancer glycolytic reprogramming to transcriptional rewiring and proposes targeting PKM2 lactylation to enhance the anti-tumor activity of bevacizumab in CRC.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE307937">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>5.</strong> â­ <strong>GSE307935 PKM2 ä¹³é…¸åŒ–ä¿ƒè¿›ç»“ç›´è‚ ç™Œè¡€ç®¡ç”Ÿæˆæ‹Ÿæ€å’Œå¯¹è´ä¼å•æŠ—æ²»ç–—çš„è€è¯æ€§ï¼Œå…¶æœºåˆ¶æ˜¯é€šè¿‡ä¿ƒè¿› FOSL1 è¶…çº§å¢å¼ºå­çš„å½¢æˆ [ATAC-seq]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€resistanceã€ATAC-seq</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Weihao Li ; Jianhong Peng ; Jiahua He ; Zhizhong Pan ; Chi Zhou ; Junzhong LinSeries Type : Genome binding/occupancy profiling by high throughput sequencingOrganism : Homo sapiensDespite the clinical utility of bevacizumab in advanced colorectal cancer (CRC), resistance remains a major challenge. Here, we unveiled a lactate-mediated mechanism driving vasculogenic mimicry (VM) and bevacizumab resistance through PKM2 lactylation. PKM2 lactylation at K206 by AARS1 promoted PKM2 nuclear translocation and interaction with FOSL1. PKM2 binding facilitated FOSL1-dependent super-enhancer formation and target gene transcription, which contributed to CRC cell VM. Genetic or pharmacological inhibition of PKM2 lactylation disrupted VM and synergized with bevacizumab in patient-derived pre-clinical models, significantly improving therapeutic efficacy. Together, this study reveals lactylation as a metabolic switch linking cancer glycolytic reprogramming to transcriptional rewiring and proposes targeting PKM2 lactylation to enhance the anti-tumor activity of bevacizumab in CRC.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE307935">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>6.</strong> <strong>GSE304885 è‚ é“æµ†ç»†èƒæ ·æ ‘çªçŠ¶ç»†èƒä¼˜å…ˆäº§ç”Ÿå¹²æ‰°ç´ Î» [scRNA-seq]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šscRNAã€regex:intestin(e|al)</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : David A Constant ; Timothy J NiceSeries Type : Expression profiling by high throughput sequencing ; OtherOrganism : Mus musculusThe healthy intestine mounts immune responses to microbiota to maintain homeostasis, which includes basal production of interferon cytokines. Previous work showed that Type III Interferon (IFN-Î») stimulates localized pockets of interferon-stimulated genes (ISGs) in the adult mouse intestinal epithelium at homeostasis that provide preemptive protection from viral pathogens. Here, we demonstrate that a major source of homeostatic IFN-Î» production in the intestine is a population of epithelium-associated plasmacytoid dendritic cells (pDC). These pDC are recruited to the intestine by bacterial microbiota colonization, and pDC depletion or bone marrow reconstitution with IFN-Î»-deficient pDC results in reduced homeostatic ISGs in the intestinal epithelium. Notably, intestinal pDC preferentially produce IFN-Î» over Type I IFNs whereas splenic pDC produce more Type I IFNs. Comparison of splenic and intestinal pDC reveal tissue-specific changes in gene expression and genomic accessibility, including evidence of response to transforming growth factor beta (TGF-Î²) in the intestine. Isolated gut pDC produce more IFN-Î» that splenic pDC upon stimulation, and pre-treatment of a human pDC cell line with TGF-Î² results in enhanced production of IFN-Î» upon stimulation. This study implicates pDC as important sources of homeostatic IFN-Î» in the intestine and defines the role of barrier cytokine TGF-Î² in regulating IFN types produced by pDC upon stimulation. Reprogramming of recruited pDC by tissue cytokines may have important implications for balancing effective antimicrobial responses with damaging inflammation at barrier tissues.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE304885">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>7.</strong> <strong>GSE304884 è‚ é“æµ†ç»†èƒæ ·æ ‘çªçŠ¶ç»†èƒä¼˜å…ˆäº§ç”Ÿå¹²æ‰°ç´ Î» [ATAC-seq]</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šATAC-seqã€regex:intestin(e|al)</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : David A Constant ; Timothy J NiceSeries Type : Genome binding/occupancy profiling by high throughput sequencingOrganism : Mus musculusThe healthy intestine mounts immune responses to microbiota to maintain homeostasis, which includes basal production of interferon cytokines. Previous work showed that Type III Interferon (IFN-Î») stimulates localized pockets of interferon-stimulated genes (ISGs) in the adult mouse intestinal epithelium at homeostasis that provide preemptive protection from viral pathogens. Here, we demonstrate that a major source of homeostatic IFN-Î» production in the intestine is a population of epithelium-associated plasmacytoid dendritic cells (pDC). These pDC are recruited to the intestine by bacterial microbiota colonization, and pDC depletion or bone marrow reconstitution with IFN-Î»-deficient pDC results in reduced homeostatic ISGs in the intestinal epithelium. Notably, intestinal pDC preferentially produce IFN-Î» over Type I IFNs whereas splenic pDC produce more Type I IFNs. Comparison of splenic and intestinal pDC reveal tissue-specific changes in gene expression and genomic accessibility, including evidence of response to transforming growth factor beta (TGF-Î²) in the intestine. Isolated gut pDC produce more IFN-Î» that splenic pDC upon stimulation, and pre-treatment of a human pDC cell line with TGF-Î² results in enhanced production of IFN-Î» upon stimulation. This study implicates pDC as important sources of homeostatic IFN-Î» in the intestine and defines the role of barrier cytokine TGF-Î² in regulating IFN types produced by pDC upon stimulation. Reprogramming of recruited pDC by tissue cytokines may have important implications for balancing effective antimicrobial responses with damaging inflammation at barrier tissues.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE304884">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>8.</strong> <strong>GSE297859 åŠèƒ±å¤©å†¬é…¶ 3 å’Œ 7 é€šè¿‡è°ƒèŠ‚å¹²ç»†èƒåŠŸèƒ½å’Œ gsdmd ä»‹å¯¼çš„ç»†èƒç„¦äº¡æ¥é™åˆ¶è‚ é“ç‚ç—‡</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šinflammationã€regex:intestin(e|al)</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Xie Wei ; Verstraeten Bruno ; Vandenabeele PeterSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusAberrant intestinal epithelial cell (IEC) death is a hallmark of inflammatory bowel disease (IBD), observed in patient samples and animal models of colitis. While multiple cell death pathways contribute to disease pathogenesis, the dominant modalities and their regulatory mechanisms in IBD remain poorly defined. In this study, we demonstrate that mice with intestinal epithelial cell-specific deletion of caspase-3 and -7 (Casp3/7 Tg) exhibit exacerbated colitis, increased mortality, and impaired epithelial regeneration, phenotypes not observed in other cell death-related knockout models. These findings highlight a previously unrecognized protective role of caspase-3/7 in controlling inflammation and tissue regeneration following intestinal injury. Mechanistically, caspase-3/7 deficiency negatively affects intestinal stem cell proliferation and promotes GSDMD-dependent pyroptosis, compromising barrier integrity and return to steady state conditions. Together, our results identify caspase-3/7 as key regulators of epithelial integrity and inflammation and suggest their modulation as a promising therapeutic strategy in IBD and colorectal cancer.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE297859">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>9.</strong> <strong>GSE240483 NAD+ æ§åˆ¶å¿ƒè„è¡°è€è¿‡ç¨‹ä¸­çš„æ˜¼å¤œèŠ‚å¾‹</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šagingã€cardiac</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Bryce J Carpenter ; Margaux Lecacheur ; Yannick N Mangold ; Kai Cui ; Stefan GÃ¼nther ; Marit W Vermunt ; Pieterjan DierickxSeries Type : Expression profiling by high throughput sequencingOrganism : Mus musculusDisruption of the circadian clock as well as reduced NAD+ levels are both hallmarks of aging. While circadian rhythms and NAD+ metabolism have been linked in heart disease, their relationship during cardiac aging is less clear. Here, we show that aging leads to disruption of diurnal gene expression in the heart. Long-term supplementation with the NAD+ precursor nicotinamide riboside (NR) boosts NAD+ levels, reprograms the diurnal transcriptome, and reverses naturally occurring cardiac enlargement in aged female mice. In addition, drastic reduction of NAD+ levels in CMs impairs PER2::luc oscillations, which is rescued by NR supplementation. Finally, we demonstrate that changes to the cardiac transcriptome due to NR treatment partially depend on the activity of SIRT1. These findings reveal an essential role for NAD+ in regulation of the cardiac circadian clock upon aging, which opens up new avenues to counteract age-related cardiac disorders.</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE240483">æŸ¥çœ‹åŸæ–‡</a></li></ul><p><strong>10.</strong> <strong>GSE309277 ä¸€ç§ç®€å•çš„æ¶²æ€3Dç»†èƒåŸ¹å…»æ¨¡å‹æ¨¡æ‹Ÿäº†ä¸è‚ºè½¬ç§»ç›¸å…³çš„ä¸Šçš®ä¹³è…ºç™Œç»†èƒçš„æ°§åŒ–çº¿ç²’ä½“ä»£è°¢</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šcancerã€metabolism</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šContributors : Balamurugan Kuppusamy ; Esta SterneckSeries Type : Expression profiling by high throughput sequencingOrganism : Homo sapiensThree-dimensional (3D) cell culture systems have emerged as powerful tools to model tumor biology ex vivo. However, the diverse array of 3D culture methods available presents challenges in selecting the most appropriate model for specific research questions. This study provides a comparative analysis of breast cancer cells (SUM149, IBC-3, MDA-MB-468) in the mammosphere culture (SphC) model or an â€œemboliâ€ culture (EmC) model, which enrich for cancer stem cells and epithelial features, respectively. The EmC model, designed originally for inflammatory breast cancer, is characterized by media viscosity and mechanical rocking of the culture vessel. Notably, cells in EmC showed a distinct and durable reduction in cell proliferation while demonstrating increased capacity to establish experimental lung metastases. Quantitative analysis of electron microscopy images suggested that cells in EmC acquire nuclear and mitochondrial features that resemble those of tumor tissue. Proteomics, single-cell transcriptomics, and metabolic flux analyses showed that cells in EmC and SphC favor mitochondrial oxidative metabolism (OXPHOS) and glycolysis, respectively. EmC rendered cells hypersensitive to OXPHOS inhibition, yet more resistant to oxidative stress. Several genes associated with lung metastasis, including ID1, were specifically enriched in EmC. Given the increasingly recognized role of OXPHOS in cancer cell survival during dissemination and as established metastases, we propose that the EmC paradigm is a suitable ex vivo model to study signaling pathways relevant for tumor tissue and to assess drug sensitivities and resistance mechanisms of metastatic breast cancer cells ex vivo</li><li>ğŸ”— <a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE309277">æŸ¥çœ‹åŸæ–‡</a></li></ul><blockquote><p>ğŸ’¡ è¯¥æ¥æºè¿˜æœ‰ 32 æ¡å†…å®¹ï¼Œè¯¦è§ <a href=#%E6%9B%B4%E5%A4%9A-%E6%95%B0%E6%8D%AE%E5%89%8D%E6%B2%BF>æ–‡æœ«</a></p></blockquote></div></details><details><summary style="text-align:right;direction:rtl;padding:10px 15px;background:linear-gradient(135deg,#f8f9fa 0%,#e9ecef 100%);border-right:4px solid #667eea;font-weight:600;cursor:pointer;margin:15px 0;border-radius:6px">ğŸ§ª åšå®¢æ›´æ–° (1æ¡)</summary><div class=details-content markdown=1><h4 id=è¯¦ç»†å†…å®¹å…¨éƒ¨1æ¡>è¯¦ç»†å†…å®¹ï¼ˆå…¨éƒ¨1æ¡ï¼‰</h4><p><strong>1.</strong> <strong>å®Œæ•´æ°¨é…°åŒ–tRNAçš„çº³ç±³å­”æµ‹åº</strong></p><ul><li>âœï¸ <strong>ä½œè€…</strong>ï¼šæœªçŸ¥ä½œè€…</li><li>ğŸ·ï¸ <strong>å…³é”®è¯</strong>ï¼šsequencing</li><li>ğŸ“ <strong>æè¿°</strong>ï¼šUsing RNA sequencing with nanopore technology, researchers developed aa tRNA seq to identify amino acids attached to individual tRNAs, revealing how modifications influence tRNA stability and charging fidelity&mldr;</li><li>ğŸ”— <a href=https://www.rna-seqblog.com/nanopore-sequencing-of-intact-aminoacylated-trnas/>æŸ¥çœ‹åŸæ–‡</a></li></ul></div></details><h2 id=-å…³é”®è¯ç»Ÿè®¡>ğŸ“Š å…³é”®è¯ç»Ÿè®¡</h2><table><thead><tr><th>å…³é”®è¯</th><th>å‡ºç°æ¬¡æ•°</th></tr></thead><tbody><tr><td>cancer</td><td>12</td></tr><tr><td>immune</td><td>9</td></tr><tr><td>RNA-seq</td><td>5</td></tr><tr><td>regex:intestin(e</td><td>al)</td></tr><tr><td>scRNA</td><td>4</td></tr><tr><td>resistance</td><td>4</td></tr><tr><td>tumor</td><td>3</td></tr><tr><td>immunity</td><td>2</td></tr><tr><td>epigenetic</td><td>2</td></tr><tr><td>single-cell</td><td>2</td></tr><tr><td>ATAC-seq</td><td>2</td></tr><tr><td>metabolic</td><td>2</td></tr><tr><td>metabolism</td><td>2</td></tr><tr><td>ChIP-seq</td><td>2</td></tr><tr><td>genome</td><td>2</td></tr><tr><td>sequencing</td><td>1</td></tr><tr><td>inflammation</td><td>1</td></tr><tr><td>aging</td><td>1</td></tr><tr><td>cardiac</td><td>1</td></tr><tr><td>RNAseq</td><td>1</td></tr></tbody></table><hr><h2 id=-æ›´å¤šå†…å®¹>ğŸ“ æ›´å¤šå†…å®¹</h2><details><summary><a name=æ›´å¤š-æ•°æ®å‰æ²¿></a>ğŸ§¬ æ•°æ®å‰æ²¿ å…¶ä»–å†…å®¹ (32æ¡)</summary><div class=details-content markdown=1><ul><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE305432">GSE305432 FOXA1/FOXM1 ChIP-seq åœ¨ giredestrant è€è¯çš„ ER+ ä¹³è…ºç™Œç»†èƒç³»ä¸­çš„åº”ç”¨</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE303505">GSE303505 ä¸Šçš®-é—´è´¨è½¬åŒ–ä¸ä¸‰é˜´æ€§ä¹³è…ºç™Œçš„å…ç–«ç»„æˆå’Œç»†èƒæ¯’æ€§åŠŸèƒ½æ”¹å˜ç›¸å…³</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE295127">GSE295127 å¯¹è€å‰ç‘åœ°å¸ä»–æ±€çš„ ER+ ä¹³è…ºç™Œç»†èƒç³»è¿›è¡Œ RNA æµ‹åº</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE304155">GSE304155 HE4 é€šè¿‡ IFN-Î³R-STAT3 è½´ä¸Šè°ƒå·¨å™¬ç»†èƒä¸Šçš„ PD-L1 è¡¨è¾¾æ¥è°ƒèŠ‚æŠ—ç™Œå…ç–«é€ƒé€¸ [LLC è‚¿ç˜¤ï¼ŒscRNA-seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298587">GSE298587 HE4 é€šè¿‡ IFN-Î³R-STAT3 è½´ä¸Šè°ƒå·¨å™¬ç»†èƒä¸Šçš„ PD-L1 è¡¨è¾¾æ¥è°ƒèŠ‚æŠ—ç™Œå…ç–«é€ƒé€¸ [RNA-Seq - ç»†èƒç³»]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE319496">GSE319496 è½¬ç§»æ€§è‚¾ç»†èƒç™Œæ‚£è€…æ¥å—çº³æ­¦åˆ©å°¤å•æŠ—è”åˆä¼ŠåŒ¹æœ¨å•æŠ—æ²»ç–—æœŸé—´ï¼Œè¡€æ¶²å‚æ•°ã€å…¨è¡€è½¬å½•ç»„è°±ä¸å…ç–«ç›¸å…³ä¸è‰¯äº‹ä»¶ä¹‹é—´çš„å…³è”</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE319387">GSE319387 ä¹³è…ºç™Œè¡€æ¸… tsRNA-Gly-5-0006ï¼šå·®å¼‚è¡¨è¾¾åŠå…¶å¯¹ç™Œç»†èƒç”Ÿç‰©å­¦çš„å½±å“</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE319070">GSE319070 SMARCA4 é€šè¿‡ H3K27 ä¹™é…°åŒ–è°ƒæ§ PROX1 ä¿ƒè¿›å‰åˆ—è…ºç™Œç»†èƒçš„è°±ç³»å¯å¡‘æ€§å’Œæ©æ‰å¢èƒºè€è¯æ€§</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE307936">GSE307936 PKM2 ä¹³é…¸åŒ–ä¿ƒè¿›ç»“ç›´è‚ ç™Œè¡€ç®¡ç”Ÿæˆæ‹Ÿæ€å’Œå¯¹è´ä¼å•æŠ—æ²»ç–—çš„è€è¯æ€§ï¼Œé€šè¿‡ä¿ƒè¿› FOSL1 è¶…çº§å¢å¼ºå­çš„å½¢æˆ [CUT&amp;Tag]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE230908">GSE230908 å¯¹å…ç–«ç»„ç»‡å’Œå™¨å®˜çš„å•ç»†èƒåˆ†ææ­ç¤ºäº†é›„æ€§æ’æ²³çŒ´çš„å…ç–«è¡°è€ç‰¹å¾</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE306946">GSE306946 ç¼ºå¤± Norrin/Î²-catenin ä¿¡å·é€šè·¯ç»„åˆ†æˆ– KIF11 æˆ– PRDX1 çš„ HREC çš„ RNA-SEQ</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE305756">GSE305756 å°é¼ è§†ç½‘è†œè¡€ç®¡ç»†èƒå•ç»†èƒè½¬å½•ç»„åˆ†ææ­ç¤ºäº†å®¶æ—æ€§æ¸—å‡ºæ€§ç»ç’ƒä½“è§†ç½‘è†œç—…å˜çš„æœºåˆ¶ã€‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE304886">GSE304886 è‚ é“æµ†ç»†èƒæ ·æ ‘çªçŠ¶ç»†èƒä¼˜å…ˆäº§ç”Ÿå¹²æ‰°ç´ Î»</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE296138">GSE296138 å…ç–«æ£€æŸ¥ç‚¹æŠ‘åˆ¶å‰‚å¯¹äººæºåŒ–åµŒåˆå°é¼ æ¨¡å‹è‚¾è„çš„å½±å“ã€‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE312696">GSE312696 é›Œæ¿€ç´ å—ä½“Î±é€šè¿‡è°ƒèŠ‚VAT Tregs (oVAT)æ¥æŠµæŠ—è‚¥èƒ–å¼•èµ·çš„ä»£è°¢åŠŸèƒ½éšœç¢</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE304776">GSE304776 LGR5âºå¹²ç»†èƒåœ¨è‚ ä¸Šçš®ç»†èƒçš„å†ç”Ÿå±‚çº§ä¸­ä¿æŒé¡¶ç«¯ä½ç½®ï¼Œæ— è®ºæ˜¯åœ¨ç¨³æ€è¿˜æ˜¯æŸä¼¤çŠ¶æ€ä¸‹</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE303999">GSE303999 scRNA-seqæ­ç¤ºæ»‘è†œç»„ç»‡ä¸­ç«¯ç²’ç»†èƒçš„è½¬å½•è°±</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE295128">GSE295128 ATACseq å¯¹ giredestrant è€è¯çš„ ER+ ä¹³è…ºç™Œç»†èƒç³»</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE294200">GSE294200 é›Œæ¿€ç´ å—ä½“Î±é€šè¿‡è°ƒèŠ‚å†…è„è„‚è‚ªç»„ç»‡è°ƒèŠ‚å› å­ï¼ˆVAT Tregsï¼‰æ¥æŠµæŠ—è‚¥èƒ–å¼•èµ·çš„ä»£è°¢åŠŸèƒ½éšœç¢</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE291529">GSE291529 åˆ©ç”¨å…¨åŸºå› ç»„ CRISPR ç­›é€‰é‰´å®šè°ƒæ§ PFOS ç»†èƒæ¯’æ€§ååº”çš„åŠŸèƒ½æ€§é—ä¼ æˆåˆ†</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE267725">GSE267725 æ ¸å—ä½“ ESRRA é€šè¿‡å¯¹è¶…çº§å¢å¼ºå­å’Œå¯åŠ¨å­çš„åŒé‡ä½œç”¨æ¥è°ƒèŠ‚åŸºå› è½¬å½•ç¨‹åºï¼Œä»è€Œä¿ƒè¿› ERÎ± é˜³æ€§ä¹³è…ºç™Œçš„å‘ç”Ÿå‘å±•</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE267724">GSE267724 æ ¸å—ä½“ ESRRA é€šè¿‡å¯¹è¶…çº§å¢å¼ºå­å’Œå¯åŠ¨å­çš„åŒé‡ä½œç”¨æ¥è°ƒèŠ‚åŸºå› è½¬å½•ç¨‹åºï¼Œä»è€Œä¿ƒè¿› ERÎ± é˜³æ€§ä¹³è…ºç™Œçš„å‘ç”Ÿã€‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE313133">GSE313133 HE4 é€šè¿‡ IFN-Î³R-STAT3 è½´ä¸Šè°ƒå·¨å™¬ç»†èƒä¸Šçš„ PD-L1 è¡¨è¾¾æ¥è°ƒèŠ‚æŠ—ç™Œå…ç–«é€ƒé€¸ [L1MKK]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE308759">GSE308759 C57BL/6å°é¼ ç¼ºè¡€/å†çŒæ³¨æŸä¼¤åçš„è½¬å½•ç»„å˜åŒ–</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE298300">GSE298300 HE4 é€šè¿‡ IFN-Î³R-STAT3 è½´ä¸Šè°ƒå·¨å™¬ç»†èƒä¸Š PD-L1 çš„è¡¨è¾¾ï¼Œä»è€Œè°ƒæ§æŠ—è‚¿ç˜¤å…ç–«é€ƒé€¸ã€‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE296417">GSE296417 CTCF åœ¨çº¢ç³»åˆ†åŒ–è¿‡ç¨‹ä¸­è°ƒèŠ‚ HBAD åŸºå› å¯åŠ¨å­çš„æŸ“è‰²è´¨å¯åŠæ€§ [ChIP-Seq]</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE317352">GSE317352 æ—©æœŸè¾…åŠ©æŠ—PD-L1ç–—æ³•å¯æ”¹å–„å°é¼ è‚ºæ¯›éœ‰èŒç—…çš„é¢„åå¹¶é€†è½¬å…ç–«éº»ç—¹</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE312091">GSE312091 RNA-seq åˆ†æäº†ç» Nr4a1 æ¿€åŠ¨å‰‚ç»†èƒå­¢å­é…® B å¤„ç†çš„ SKG å°é¼ ä¸­ TCR åˆºæ¿€çš„ CD4âº T ç»†èƒã€‚</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE290820">GSE290820 å·¥ç¨‹æ”¹é€ å›ºæœ‰æ— åºåŒº (IDR) ä»¥å¼•å¯¼åŸºå› ç»„å¯¼èˆª</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE289561">GSE289561 Long-term chronic exposure of mice to sodium fluoride and a mixture of endocrine disruptors lead to easily observable tooth enamel and retina abnormalities underlying changes in hepatic metabolism</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE286416">GSE286416 å¤šå°ºåº¦é…ªæ°¨é…¸æ¿€é…¶æŠ‘åˆ¶å‰‚å¿ƒè„æ¯’æ€§åˆ†ææ­ç¤ºæœºæ¢°æ•æ„Ÿæ€§ç¦»å­é€šé“ PIEZO1 å…·æœ‰å¿ƒè„ä¿æŠ¤ä½œç”¨</a></li><li><a href="http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE126178">GSE126178 é“¬æš´éœ²çš„æ—¶é—´è¿›ç¨‹ï¼ˆRNA-Seqï¼‰</a></li></ul></div></details><hr><p><em>ğŸ“… æŠ¥å‘Šç”Ÿæˆæ—¶é—´ï¼š2026-02-14 21:43</em><br><em>ğŸ¤– ç”± GitHub Actions è‡ªåŠ¨ç”Ÿæˆ</em></p></div><footer class=post__footer><div class="post__tags tags clearfix"><svg class="tags__badge icon icon-tag" width="16" height="16" viewBox="0 0 32 32"><path d="M4 0h8s2 0 4 2l15 15s2 2 0 4L21 31s-2 2-4 0L2 16s-2-2-2-4V3s0-3 4-3m3 10a3 3 0 000-6 3 3 0 000 6"/></svg><ul class=tags__list><li class=tags__item><a class="tags__link btn" href=../../../tags/research/ rel=tag>Research</a></li><li class=tags__item><a class="tags__link btn" href=../../../tags/daily/ rel=tag>Daily</a></li><li class=tags__item><a class="tags__link btn" href=../../../tags/week072026/ rel=tag>Week072026</a></li></ul></div></footer></article></main><div class="authorbox clearfix"><div class=authorbox__header><span class=authorbox__name>About Bloger</span></div></div><nav class="pager flex"><div class="pager__item pager__item--prev"><a class=pager__link href=../../../posts/dailyreports/2026-02-14/ rel=prev><span class=pager__subtitle>Â«&#8201;Previous</span><p class=pager__title>ç§‘ç ”æ—¥æŠ¥ 2026-02-14</p></a></div><div class="pager__item pager__item--next"><a class=pager__link href=../../../posts/dailyreports/2026-02-16/ rel=next><span class=pager__subtitle>Next&#8201;Â»</span><p class=pager__title>ç§‘ç ”æ—¥æŠ¥ 2026-02-16</p></a></div></nav><section class=comments><div id=disqus_thread></div><script>window.disqus_config=function(){},function(){if(["localhost","127.0.0.1"].indexOf(window.location.hostname)!=-1){document.getElementById("disqus_thread").innerHTML="Disqus comments not available by default when the website is previewed locally.";return}var t=document,e=t.createElement("script");e.async=!0,e.src="//kkitown.disqus.com/embed.js",e.setAttribute("data-timestamp",+new Date),(t.head||t.body).appendChild(e)}()</script><noscript>Please enable JavaScript to view the <a href=https://disqus.com/?ref_noscript>comments powered by Disqus.</a></noscript><a href=https://disqus.com class=dsq-brlink>comments powered by <span class=logo-disqus>Disqus</span></a></section></div><aside class=sidebar><div class="widget-search widget"><form class=widget-search__form role=search method=get action=https://google.com/search><input class=widget-search__field type=search placeholder=Searchâ€¦ name=q aria-label=Searchâ€¦>
<input class=widget-search__submit type=submit value=Search>
<input type=hidden name=sitesearch value=https://ixxmu.github.io/></form></div><div class="widget-recent widget"><h4 class=widget__title>Recent Posts</h4><div class=widget__content><ul class=widget__list><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-02-26/>ç§‘ç ”æ—¥æŠ¥ 2026-02-26</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-02-25/>ç§‘ç ”æ—¥æŠ¥ 2026-02-25</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-02-24/>ç§‘ç ”æ—¥æŠ¥ 2026-02-24</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-02-23/>ç§‘ç ”æ—¥æŠ¥ 2026-02-23</a></li><li class=widget__item><a class=widget__link href=../../../posts/dailyreports/2026-02-22/>ç§‘ç ”æ—¥æŠ¥ 2026-02-22</a></li></ul></div></div><div class="widget-categories widget"><h4 class=widget__title>Categories</h4><div class=widget__content><ul class=widget__list><li class=widget__item><a class=widget__link href=../../../categories/dailyreport/>DailyReport</a></li><li class=widget__item><a class=widget__link href=../../../categories/learnr/>LearnR</a></li></ul></div></div><div class="widget-taglist widget"><h4 class=widget__title>Tags</h4><div class=widget__content><a class="widget-taglist__link widget__link btn" href=../../../tags/daily/ title=Daily>Daily (119)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/research/ title=Research>Research (119)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week022026/ title=Week022026>Week022026 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week032026/ title=Week032026>Week032026 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week042026/ title=Week042026>Week042026 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week052026/ title=Week052026>Week052026 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week062026/ title=Week062026>Week062026 (6)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week072026/ title=Week072026>Week072026 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week082026/ title=Week082026>Week082026 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week452025/ title=Week452025>Week452025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week462025/ title=Week462025>Week462025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week472025/ title=Week472025>Week472025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week482025/ title=Week482025>Week482025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week492025/ title=Week492025>Week492025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week502025/ title=Week502025>Week502025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week512025/ title=Week512025>Week512025 (7)</a>
<a class="widget-taglist__link widget__link btn" href=../../../tags/week522025/ title=Week522025>Week522025 (7)</a></div><a href=../../../tags/></a></div><div class="widget-social widget"><h4 class="widget-social__title widget__title">Social</h4><div class="widget-social__content widget__content"><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Facebook rel="noopener noreferrer" href=https://facebook.com/username target=_blank><svg class="widget-social__link-icon icon icon-facebook" width="24" height="24" viewBox="0 0 352 352"><path d="m0 32v288c0 17.5 14.5 32 32 32h288c17.5.0 32-14.5 32-32V32c0-17.5-14.5-32-32-32H32C14.5.0.0 14.5.0 32zm320 0v288h-83V212h41.5l6-48H237v-31c0-14 3.5-23.5 23.5-23.5h26V66c-4.4-.6-19.8-1.5-37.5-1.5-36.9.0-62 22.2-62 63.5v36h-42v48h42v108H32V32z"/></svg>
<span>Facebook</span></a></div><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Twitter rel="noopener noreferrer" href=https://twitter.com/username target=_blank><svg class="widget-social__link-icon icon icon-twitter" width="24" height="24" viewBox="0 0 384 312"><path d="m384 36.9c-14.1 6.3-29.3 10.5-45.2 12.4 16.3-9.7 28.8-25.2 34.6-43.6-15.2 9-32.1 15.6-50 19.1-14.4-15.2-34.9-24.8-57.5-24.8-43.5.0-78.8 35.3-78.8 78.8.0 6.2.7 12.2 2 17.9-65.5-3.3-123.5-34.6-162.4-82.3C20 26 16.1 39.6 16.1 54c0 27.3 13.9 51.4 35 65.6-12.9-.4-25.1-4-35.7-9.9v1c0 38.2 27.2 70 63.2 77.2-6.6 1.8-13.6 2.8-20.8 2.8-5.1.0-10-.5-14.8-1.4 10 31.3 39.1 54.1 73.6 54.7-27 21.1-60.9 33.7-97.8 33.7-6.4.0-12.6-.4-18.8-1.1C34.9 299 76.3 312 120.8 312c144.9.0 224.1-120 224.1-224.1.0-3.4-.1-6.8-.2-10.2 15.4-11.1 28.7-25 39.3-40.8z"/></svg>
<span>Twitter</span></a></div><div class="widget-social__item widget__item"><a class="widget-social__link widget__link btn" title=Instagram rel="noopener noreferrer" href=https://www.instagram.com/username target=_blank><svg class="widget-social__link-icon icon icon-instagram" width="24" height="24" viewBox="0 0 256 256"><circle cx="193" cy="59" r="15"/><path fill-rule="evenodd" d="M101 0h54c41 0 58.4 3.9 74.5 17C256.2 37.5 256 74.8 256 97.7v60c0 26.7.0 60.4-26.5 81.4-16 13.4-33.5 16.9-74.5 16.9h-54c-41 0-57.5-3.5-74.5-16.9C1 218.9.5 186.3.1 160.5L0 155V97.7c0-23-.2-60.2 26.5-80.7C45 2 60 0 101 0zm4.9 23h44.3c45.8.0 58.3 3.5 70.3 17.5 11.8 13.2 12 30.1 12.5 62.9V156c.2 20.8.3 45.8-12.5 59.5-12 14-24.5 17.5-70.3 17.5h-44.3c-45.9.0-57.3-3.5-70.4-17.5-12.2-13-12.3-36.5-12.4-56.7v-55.6c.4-32.6.7-49.6 12.4-62.7C48 26.5 60 23 105.9 23zm19.6 144.5a42 42 0 100-84 42 42 0 000 84zm0 22.5a64.5 64.5.0 100-129 64.5 64.5.0 000 129z"/></svg>
<span>Instagram</span></a></div></div></div></aside></div><footer class=footer><div class="container footer__container flex"><div class=footer__copyright>&copy; 2026 ç”Ÿä¿¡æ™®æ‹‰æ–¯.
<span class=footer__copyright-credits>Generated with <a href=https://gohugo.io/ rel="nofollow noopener" target=_blank>Hugo</a> and <a href=https://github.com/Vimux/Mainroad/ rel="nofollow noopener" target=_blank>Mainroad</a> theme.</span></div></div></footer></div><script async defer src=../../../js/menu.js></script><script src=../../../js/custom.js></script><script src="https://cdnjs.cloudflare.com/ajax/libs/mathjax/2.7.6/MathJax.js?config=TeX-AMS-MML_HTMLorMML" async></script></body></html>